Abstract Objective To study the association of different maternal and infant factors with the number of total nucleated cells and CD34+ hematopoietic stem/progenitor cells in umbilical cord blood, and to provide a reference for reasonable selection of umbilical cord blood in the cord blood bank. Methods A prospective study was performed for the umbilical cord blood samples of 130 neonates who were born in Dalian Women and Children's Medical Center from June 2019 to January 2020, with a male/female ratio of 1:1. Related perinatal information was collected, including maternal age and blood type, presence or absence of gestational diabetes or gestational hypertension, pregnancy method, mode of delivery, singleton pregnancy/twin pregnancy, body weight and sex of neonates, Apgar score after birth, and the conditions of placenta, amniotic fluid, and umbilical cord. Results The neonates were grouped according to maternal blood type, gestational diabetes, gestational hypertension, pregnancy method, mode of delivery, singleton pregnancy/ twin pregnancy, sex of neonates, Apgar score after birth, placental morphology, meconium staining of amniotic fluid, and umbilical cord around the neck. The comparison between groups showed no significant differences in the numbers of total nucleated cells and CD34+ cells in umbilical cord blood (P > 0.05). Maternal age and neonatal body weight were not correlated with the number of total nucleated cells in umbilical cord blood (P > 0.05), and neonatal body weight was not correlated with the number of CD34+ cells (P > 0.05), while maternal age was positively correlated with the number of CD34+ cells (P < 0.05). Conclusions The number of CD34+ cells in umbilical cord blood increases with the increase in maternal age, and therefore, umbilical cord blood in the cord blood bank may be selected based on maternal age.
HE Jing,YANG Yue-Ming,LIU Ling et al. Influence of maternal and infant factors on CD34+ hematopoietic stem/progenitor cells in umbilical cord blood[J]. CJCP, 2021, 23(1): 43-48.
HE Jing,YANG Yue-Ming,LIU Ling et al. Influence of maternal and infant factors on CD34+ hematopoietic stem/progenitor cells in umbilical cord blood[J]. CJCP, 2021, 23(1): 43-48.
Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling[J]. N Engl J Med, 1989, 321(17):1174-1178.
[8]
Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group[J]. N Engl J Med, 1997, 337(6):373-381.
[9]
Tanaçan A, Yurdakul P, Aktoz F, et al. Factors influencing the success of cord blood collection:a tertiary perinatal medicine center's experience[J]. Turk J Med Sci, 2018, 48(5):961-966.
[10]
Fernandes JF, Rocha V, Labopin M, et al. Transplantation in patients with SCID:mismatched related stem cells or unrelated cord blood?[J]. Blood, 2012, 119(12):2949-2955.
[11]
Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation:the first 25 years and beyond[J]. Blood, 2013, 122(4):491-498.
[12]
Bielec-Berek B, Jastrzębska-Stojko Ż, Drosdzol-Cop A, et al. Maternal predictors and quality of umbilical cord blood units[J]. Cell Tissue Bank, 2018, 19(1):69-75.
[13]
Omori A, Takahashi K, Hazawa M, et al. Maternal and neonatal factors associated with the high yield of mononuclear lowdensity/CD34+ cells from placental/umbilical cord blood[J]. Tohoku J Exp Med, 2008, 215(1):23-32.
[14]
Keersmaekers CL, Mason BA, Keersmaekers J, et al. Factors affecting umbilical cord blood stem cell suitability for transplantation in an in utero collection program[J]. Transfusion, 2014, 54(3):545-549.
[15]
Hadarits O, Zóka A, Barna G, et al. Increased proportion of hematopoietic stem and progenitor cell population in cord blood of neonates born to mothers with gestational diabetes mellitus[J]. Stem Cells Dev, 2016, 25(1):13-17.
[16]
Kong CM, Subramanian A, Biswas A, et al. Changes in stemness properties, differentiation potential, oxidative stress, senescence and mitochondrial function in Wharton's jelly stem cells of umbilical cords of mothers with gestational diabetes mellitus[J]. Stem Cell Rev Rep, 2019, 15(3):415-426.
[17]
Keersmaekers CL, Mason BA, Keersmaekers J, et al. Factors affecting umbilical cord blood stem cell suitability for transplantation in an in utero collection program[J]. Transfusion, 2014, 54(3):545-549.
[18]
Wu S, Xie G, Wu J, et al. Influence of maternal, infant, and collection characteristics on high-quality cord blood units in Guangzhou Cord Blood Bank[J]. Transfusion, 2015, 55(9):2158-2167.
[19]
Nordin F, Idris MRM, Mahdy ZA, et al. Preeclampsia in pregnancy affecting the stemness and differentiation potency of haematopoietic stem cell of the umbilical cord blood[J]. BMC Pregnancy Childbirth, 2020, 20(1):399.
[20]
Ahmed SM, Khalil HB. Comparative assessment of stem cells count, viability and hematological parameters of umbilical cord blood in healthy and preeclampsia deliveries[J]. Afr J Med Sci, 2018, 3(12):1-5.
[21]
Al-Qahtani R, Al-Hedythi S, Arab S, et al. Factor predicting total nucleated cell counts in cord blood units[J]. Transfusion, 2016, 56(9):2352-2354.
[22]
Chandra T, Afreen S, Kumar A, et al. Correlation of umbilical cord blood volume with CD34+ cells concentration[J]. Int J Blood Transfus Immunohematol, 2011, 1:12-16.
[23]
Abdelrazik AM, El Said MN, Abdelaziz HE, et al. The impact of fetal and maternal physiologic factors on umbilical cord blood quality as a source of stem cells in Egyptian population[J]. Transfusion, 2015, 55(12):2882-2889.
[24]
Mazzoccoli G, Miscio G, Fontana A, et al. Time related variations in stem cell harvesting of umbilical cord blood[J]. Sci Rep, 2016, 6:21404.
[25]
Cobellis L, Castaldi MA, Trabucco E, et al. Cord blood unit bankability can be predicted by prenatal sonographic parameters[J]. Eur J Obstet Gynecol Reprod Biol, 2013, 170(2):391-395.
[26]
Akyurekli C, Chan JY, Elmoazzen H, et al. Impact of ethnicity on human umbilical cord blood banking:a systematic review[J]. Transfusion, 2014, 54(8):2122-2127.
[27]
Al-Sweedan SA, Musalam L, Obeidat B. Factors predicting the hematopoietic stem cells content of the umbilical cord blood[J]. Transfus Apher Sci, 2013, 48(2):247-252.
[28]
Hussein AA, Bawadi RM, Tahtamouni LH, et al. Feasibility of collecting umbilical cord blood in Jordan and the effect of maternal and neonatal factors on hematopoietic stem cell content[J]. Mediterr J Hematol Infect Dis, 2014, 6(1):e2014019.
[29]
Nguyen PH, Nguyen VT, Chu TT, et al. Factors affecting human umbilical cord blood quality before cryopreservation:the importance of birth weight and gestational age[J]. Biopreserv Biobank, 2020, 18(1):18-24.
[30]
Servais S, Baudoux E, Brichard B, et al. Circadian and circannual variations in cord blood hematopoietic cell composition[J]. Haematologica, 2015, 100(1):e32-e34.
[31]
Bijou F, Ivanovic Z, Fizet D, et al. Neonatal sex and weight influence CD34(+) cell concentration in umbilical cord blood but not stromal cell-derived factor 1-3'A polymorphism[J]. Cytotherapy, 2015, 17(1):68-72.
[32]
Lim FT, Scherjon SA, van Beckhoven JM, et al. Association of stress during delivery with increased numbers of nucleated cells and hematopoietic progenitor cells in umbilical cord blood[J]. Am J Obstet Gynecol, 2000, 183(5):1144-1152.
LI Qian-Qian, DONG Xiao-Yue, QIAO Yu, YIN Yu-Jie, GAO Yan, ZHOU Jin-Jun, YANG Li, ZHU Rong-Ping, WANG Fu-Dong, WAN Jun, XU Yan, PAN Zhao-Jun, WANG Wei-Yuan, YAN Jun-Mei, HAN Shu-Ping, LU Hong-Yan, HU Yu-Hua, LI Shuang-Shuang, WANG Jin-Xiu, WU Ming-Fu, WANG Jun, DENG Xiao-Yi, YU Zhang-Bin. An investigation of severe neonatal hyperbilirubinemia in 13 hospitals of Jiangsu Province, China[J]. CJCP, 2020, 22(7): 690-695.
